November 28, 2014 4:58 AM ET

Biotechnology

Company Overview of Tobira Therapeutics, Inc.

Executive Profile

Andrew Asa Hindman M.B.A

Chief Business Development Officer, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

----

Background

Mr. Andrew Asa Hindman M.B.A has been the Chief Business Development Officer of Acorda Therapeutics, Inc. since May 2014. Mr. Hindman held several senior executive level positions in the biopharmaceutical industry. Mr. Hindman served as the Chief Executive Officer and President of Tobira Therapeutics, Inc. since April 2011. At Tobira, he was responsible for developing a new corporate strategy, building new leadership and operational teams, and raising operating capital. ...

Corporate Headquarters

701 Gateway boulevard
South San Francisco, California 94080

United States

Phone: 650-741-6625
Fax: --

Board Members Memberships

Former Chief Executive Officer, President and Director

Education

MBA
Columbia Business School
BA
Wesleyan University
MBA
Columbia University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
$3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tobira Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.